Pages
Flu - make an informed CHOICE this year
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/flu-make-informed-choice-year
Self-management facilitator service
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/self-management-facilitator-service
Turf cutting marks the start on site for £10.5 million new health hub in Bakewell
https://dchs.nhs.uk/news/turf-cutting-marks-start-site-105-million-new-health-hub-bakewell
IT equipment amnesty - we need your help please!
IT equipment amnesty - we need your help please!
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/it-equipment-amnesty
National Inclusion Week 2022
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/national-inclusion-week-2022
Files
Incident Reporting Policy (P80)
Derbyshire Community Health Services (DCHS) NHS Foundation Trust is committed to ensuring the safety of patients, staff, visitors, and contractors alike. DCHS aspires to provide a Zero Harm environment. The policy considers the recommendations of the Department of Health publications: An Organisation with a Memory, Building a Safer NHS, Doing less Harm and the former National Patient Safety Agency (NPSA) publication Building a memory: preventing harm, reducing risks and improving patient safety, Berwick report 2013 and the Health and Safety at Work etc. Act 1974 and subsequent subsidiary reports. The reporting, management and investigation of adverse incidents are fundamental elements of risk management. Sharing the learning from adverse incidents (including near misses) enables the organisation to implement changes to practice, processes, and systems so that the risk of harm is reduced. In addition to the human costs, if incidents are not properly managed, they may result in a loss of public confidence in the organisation and a loss of assets.
SOP for the supply or issue of Steroid Emergency Cards (S87)
Identify / supply to patients who require a Steroid Emergency card in the Community Hospitals setting, Urgent Treatment Centres, Podiatric Surgery, Integrated Community teams and specialist services such as Respiratory teams and Physiotherapy if a new Steroid Emergency card is needed or a Steroid Emergency Card has been lost
Rapid Tranquilisation Guidelines (G52)
The aim of this guidance is to support practitioner’s decision making, when using medication by the parenteral route, when the use of oral medication is not possible or appropriate and urgent sedation with medication is required. NICE Guidance NG10 (2015)
DCHS Safeguarding Supervision Policy (P15)
Safeguarding supervision is recognised by DCHS FT as an important element within clinical supervision and the safety culture. In addition to an individual’s knowledge, skills, experience and training, effective safeguarding practice relies on a professional’s curiosity and vigilance. Safeguarding supervision provides an opportunity to both sustain and foster these qualities and ensure staff are updated on current safeguarding issues, legislation and outcomes of recent Child Practice Reviews (CPR), Serious Incident Learning Reviews (SILR), Domestic Homicide Reviews (DHR), and Safeguarding Adult Reviews (SAR). This policy covers both Adult and Children
Intravenous Therapy and Vascular Access Device (VAD) Policy - Adults (P47)
The use of intravenous medicines has many healthcare benefits for patients. Intravenous medicines are increasingly commonplace within the community setting and the need for an intravenous medicine is often a reason for patient’s being admitted to secondary care. Following the implementation of national and local policy, there is a new direction for community care providers such as DCHS to develop services that can be provided within the community hospital or community setting to accommodate patient’s being able to receive more complex care. The aims of this policy are: To prevent unnecessary acute hospital admission and to facilitate early discharge from the acute hospital setting by enabling patients to receive IV medicines safely within their own home or a community health care setting. To ensure an IV medicine is the most appropriate treatment for the patient and that it is administered via the most appropriate Vascular Access Device, the most appropriate vascular access site is chosen and the IV medicine is administered at the right time. To reduce the risk of complications by ensuring registered practitioners’ practice safely and consistently in relation to the administration of IV medicines, Vascular Access Device Insertion and the care and maintenance of Vascular Access Devices (VADs), through the implementation of evidence-based practice and by providing staff with the necessary guidance on clinical practice and training. To preserve and promote patient vessel health in the short and long term by ensuring any Vascular Access Device inserted is the most appropriate device for the treatment being administered and that it is placed by the most appropriately qualified practitioner.
Media Consent Form - 2024
Media consent form
Recognition of the Deteriorating Child Policy (P93)
The aim of this policy is to set the minimum standard and frequency for monitoring and recording Child patients’ vital signs in their own home, Urgent Treatment Centres and Outpatient Podiatric Surgery. The mismanagement of deterioration is a common area of systemic failure in avoidable patient death across the NHS and poor communication is a leading cause of adverse events in healthcare. The Paediatric Observation Priority Score (POPS) offers a common language to describe and communicate a child’s acute illness severity by all healthcare professionals in all settings and is central to establishing a national pathway for improving the management of deterioration and sepsis.
Veteran Aware Information Leaflet
DCHS Veteran Aware information leaflet - July 2022; includes our commitment to the armed forces community when accessing healthcare
2022 10 06 Board Pack.pdf
October 2022 - DCHS Trust Board Meeting
Patient (or carer) Initiated Follow-up SOP Dementia Palliative Care Service (S132)
Patient initiated follow-up (PIFU) describes when a patient (or their carer) can initiate their follow-up visit as and when required, e.g., when symptoms or circumstances change. This SOP defines the process, roles, and responsibilities for the following: • Identifying which patients PIFU is right for • Moving a patient onto a PIFU pathway • Booking visits which have been initiated by a patient or carer • Managing patients who do not initiate a review/home visit within the PIFU timescale • Discharging or booking reviews at the end of that patient’s PIFU timescale • Monitoring compliance Dementia Palliative Care Service are in the process of piloting a PIFU process for 12 months. The pilot will be reviewed every 3 months with a final review post 12 months.